Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory.
Major depressive disorder is often associated with deficits in social and cognitive functioning. Mice transgenic for acid sphingomyelinase (t-ASM) were previously shown to have a depressive-like phenotype, which could be normalized by antidepressant treatment. Here, we investigated whether t-ASM mice show deficits in social behavior and memory performance, and whether these possible deficits might be normalized by amitriptyline treatment. Our results revealed that ASM overexpression altered the behavior of mice in a sex-dependent manner. As such, t-ASM female, but not male, mice showed an impaired social preference and a depressive- and anxiogenic-like phenotype, which could be normalized by amitriptyline treatment. Both male and female t-ASM mice showed unaltered preference for social novelty, novel object recognition, and social and object discrimination abilities. Amitriptyline treatment impaired novel object recognition and object discrimination abilities in female, but not in male, wild-type mice, while female t-ASM mice showed unaltered novel object recognition and object discrimination abilities. This study suggests that female t-ASM mice represent a model of depression with comorbid anxiety and social deficits, without memory impairments. It further suggests that ASM overexpression has a protective role against the detrimental effects of amitriptyline on female, but not on male, non-social (object) memory.
Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Iulia
I
Zoicas
Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Martin
M
Reichel
Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
Erich
E
Gulbins
Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Johannes
J
Kornhuber
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001007:Anxiety / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology; D001522:Behavior, Animal / Q000187:drug effects; D003863:Depression / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000187:drug effects; D005260:Female; D015870:Gene Expression; D008297:Male; D008568:Memory / Q000187:drug effects*; D051379:Mice; D008822:Mice, Transgenic; D010364:Pattern Recognition, Visual / Q000187:drug effects; D012737:Sex Factors; D012919:Social Behavior; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics* / Q000378:metabolism; D019076:Transgenes
D000929:Antidepressive Agents, Tricyclic; D000639:Amitriptyline; C112980:acid sphingomyelinase-1; D013108:Sphingomyelin Phosphodiesterase